Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients.

Status:
Completed

Trial end date:
2010-08-01

Target enrollment:

Participant gender:

The purpose of this study is to determine whether 2 weeks of treatment with AZD1446 compared to placebo improves ADHD symptoms and is well tolerated.

Phase 2

AstraZeneca